Simultaneous suppression of the MAP kinase and NF-κB pathways provides a robust therapeutic potential for thyroid cancer

Koji Tsumagari, Zakaria Y. Abd Elmageed, Andrew B. Sholl, Paul Friedlander, Mohamed Abdraboh, Mingzhao Xing, A. Hamid Boulares, Emad Kandil

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Simultaneous suppression of the MAP kinase and NF-κB pathways provides a robust therapeutic potential for thyroid cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences